R. Ganschow et al., B-cell dysfunction and depletion using mycophenolate mofetil in a pediatric combined liver and kidney graft recipient, PEDIAT TRAN, 5(1), 2001, pp. 60-63
The use of mycophenolate mofetil (MMF) in combination with cyclosporin A (C
sA) and steroids is well established after kidney transplantation (Tx) in c
hildren. A 9-yr-old girl with primary hyperoxaluria type 1 and systemic oxa
losis underwent a combined kidney and liver Tx at our institution. The post
-operative immunosuppression consisted of CsA, prednisolone, and MMF, Four
weeks post-transplant the girl suffered from a severe urinary tract infecti
on caused by Pseudomonas aeruginosa, when the serum immunoglobulin G (IgG)
concentration was found to be critically low (<1.53 g/L). Additionally, the
re was an isolated B-cell depletion (240/ muL) at that time. In the followi
ng course, the B-cell count was significantly diminished until the MMF was
stopped 13 weeks posttransplant. As a result of the very low serum IgG conc
entration, intravenous immunoglobulin (IVIG) substitution was necessary. Th
ere was no significant loss of immunoglobulins in the ascites and urine and
no other medication with possible side-effects on B cells was given. We su
ggest that MMF can lead to suppressed IgG production by B cells and can cau
se a defective differentiation into mature B cells. In vitro studies demons
trated these effects of MMF on B cells, but no in vivo cases of this phenom
enon have been reported. B-cell counts and serum IgG concentrations returne
d to normal values after discontinuing the MMF, As we can assume that the o
bserved B-cell dysfunction and depletion were MMF related, we suggest that
serum Ige concentrations should be monitored when MMF is used after solid-o
rgan Tx.